Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 21.5 to 17.8.
-
Busy address KBO
51 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Across Health from Gent, company number BE0894968223, closed financial year 2025 with a result of € -92,440 after tax. For that financial year Across Health recorded revenue of € 12.2 million and equity of € 14.3 million. Compared with financial year 2024, the result moved from € 6.4 million to € -92,440. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 14.3 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -92,440
▼ still € 6.4 million profit in 2024
Profit after tax over the fiscal year.
€ 2.4 million
▲ 159% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 8.4 million.
People and assets in 2025
17.8
▼ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.4 million
▼ 6% vs 2024
€ 134,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.4 million
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 52 days on average.
€ 772,647
▼ 36% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 17,115,056 | € 18,206,140 | € 14,545,618 | € 12,208,016 | ▼ 16% |
| Profit after taxes | € 6,098,574 | € 6,524,343 | € 6,390,966 | € -92,440 | ▼ € 6.5 million |
| Equity | € 18,860,805 | € 27,282,496 | € 14,428,705 | € 14,336,265 | ▼ 1% |
| Total debts | € 7,616,507 | € 4,539,916 | € 6,087,811 | € 3,930,611 | ▼ 35% |
| Cash | € 6,892,930 | € 2,712,079 | € 938,774 | € 2,428,135 | ▲ 159% |
| Retained profit | € 18,530,680 | € 21,316,064 | € 8,462,273 | € 8,369,833 | ▼ 1% |
| Dividend | € 0 | € 0 | € 19,244,758 | € 0 | ▼ 100% |
| Balance sheet total | € 26,477,313 | € 31,822,412 | € 20,516,516 | € 18,266,876 | ▼ 11% |
| Employees (FTE) | 18.4 | 21.5 | 18.6 | 17.8 | ▼ 0.8 |
Key figures of Across Health, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Across Health?
What happened at Across Health in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Takydromus BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 92,440 (▼ € 6.5 million vs 2024). Source: NBB ↗
- Ruud Kooi stepped down as director. NBB
- Stacey Hanna stepped down as director. NBB
- Takydromus BV became a director. NBB
- Matthew DeZee stepped down as director. NBB
- Mazurek Krzysztof stepped down as director. NBB
- Stacey Hanna became a director. NBB
In short
From € 6.1 million profit in 2022 to € 92,440 loss in 2025.
Paid € 3.6 million in corporate taxes since 2022.
Best year ever: 2023, with € 6.5 million profit.
Paid out € 19.2 million in dividends to the owners in total.
A new publication or filing at Across Health? We notify you, reason included.
Follow Across HealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Across Health is Geert Dierckx. It owns 100% of Precision AQ (FR), 100% of Precision AQ (DE), 100% of Precision AQ (ES) and 100% of Precision AQ (NL) itself.
Directors
According to the 2025 annual accounts
Geert Dierckx
Persoon belast met dagelijks bestuur
since 2023
Mazurek Krzysztof
Director
since 2021 · until 2025
Ruud Kooi
Persoon belast met dagelijks bestuur
since 2023 · until 2026
Stacey Hanna
Director
since 2024 · until 2026
Director · represented by Schenck Alfons
since 2026 · until 2032
Matthew DeZee
Director
since 2021 · until 2026
Establishments
Establishment units
Physical locations of this company
Ottergemsesteenweg-Zuid 808 box B 332
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 51 companies are registered at this address.
All companies at this address →Schaeffler Belgium
€ 21.9 million revenue · 2025
KONINKLIJKE ATHLETIEK ASSOCIATIE GENT - Voetbalafdeling
€ 37.5 million revenue · 2025
Bontinck Architecture and Interior NV
€ 2.5 million revenue · 2026
Sales Management Association Belgium
KAAG Management
€ 136,551 gross margin · 2025
+46 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0894.968.223
- VAT number
- BE 0894.968.223
- Registered office
- Ottergemsesteenweg-Zuid 808 bus B 332, 9000 Gent
- Names & denominations
- Across Health
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2008
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie